Cargando…
Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
IMPORTANCE: National Cancer Institute Clinical Trial Network (NCTN) groups serve a vital role in identifying effective new antineoplastic regimens. However, the downstream clinical effect of their trials has not been systematically examined. OBJECTIVE: To examine the association of NCTN trials with...
Autores principales: | Unger, Joseph M., Nghiem, Van T., Hershman, Dawn L., Vaidya, Riha, LeBlanc, Michael, Blanke, Charles D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727679/ https://www.ncbi.nlm.nih.gov/pubmed/31483471 http://dx.doi.org/10.1001/jamanetworkopen.2019.10593 |
Ejemplares similares
-
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
por: Unger, Joseph M., et al.
Publicado: (2020) -
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic
por: Unger, Joseph M., et al.
Publicado: (2021) -
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
por: Vaidya, Riha, et al.
Publicado: (2022) -
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2020) -
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
por: Unger, Joseph M, et al.
Publicado: (2020)